Lawson Macartney - May 16, 2023 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
May 16, 2023
Transactions value $
-$364,960
Form type
4
Date filed
5/18/2023, 06:30 PM
Previous filing
Apr 24, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $19K +16K +33.36% $1.19* 64K May 16, 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Sale -$384K -16K -25.01% $24.00 48K May 16, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Options Exercise $0 -16K -100% $0.00* 0 May 16, 2023 Common Stock 16K $1.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.